-
Product Insights
Low-Grade Astrocytoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Low-Grade Astrocytoma Global Clinical Trials Review, H2, 2017" provides an overview of Low-Grade Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Low-Grade Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Low-Grade Glioma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H2, 2017" provides an overview of Low-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Low-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphoblastic Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Malignant Ascites Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H2, 2017" provides an overview of Malignant Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EpiCast Report: Supportive Care in Oncology – Epidemiology Forecast to 2026
Cancer is a broad term for a group of diseases characterized by uncontrolled cell proliferation. Worldwide, it is estimated that 14 million new cases of cancer are diagnosed each year, and 30–50% of those cases are preventable (WHO, 2017). Cancer is the second leading cause of death worldwide, with more than eight million deaths caused by cancer in 2015 (WHO, 2017). GlobalData epidemiologists provide the number of diagnosed incident cases of all cancer treated with chemotherapy and the number of...
-
Sector Analysis
PharmaFocus: Supportive Care in Oncology
Supportive care in oncology is a broad term that is composed of indications that are either a symptom of a patient’s cancer or a side effect of cancer treatment. This report focuses on six prominent cancer supportive care indications: chemotherapy-induced nausea and vomiting (CINV), cancer cachexia, oral mucositis, bone metastases, chemotherapy-induced neutropenia (CIN), and chemotherapy-induced anemia (CIA). There is a consensus among KOLs across the 7MM that supportive oncology had not been given much priority by physicians and institutions in...
-
Product Insights
Hypopharyngeal Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypopharyngeal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Hypopharyngeal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hypopharyngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EpiCast Report: Melanoma – Epidemiology Forecast to 2026
Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of skin. Melanoma is considered an aggressive form of cancer; however, if caught early, it can be treated very successfully. Melanoma is one of the most common cancer types in the US, and is considered the national cancer of Australia. Melanoma risk factors include increasing age, sex, fair complexion, excessive ultraviolet (UV) light exposure, history of sunburn, having many...
-
Product Insights
Intestinal Cancer Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H2, 2017" provides an overview of Islet Cell Carcinoma (Insulinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Islet Cell Carcinoma (Insulinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.